Additionally, young women who develop breast cancer under the age of 40 (YWBC) harbor deleterious germline mutations in BRCA1 (gBRCA1m) or BRCA2 (gBRCA2m) in approximately 12% of cases [6,7,8]. Here, BRCA2 is linked to breast carcinoma.